Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sclerostin

1 Jan 2010

Abstract excerpt

The striking clinical benefits of intermittent parathyroid hormone in osteoporosis have begun a new era of skeletal anabolic agents. One potential new agent is monoclonal antibody to sclerostin, a potent inhibitor of osteoblastogenesis.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone health and treatments
Share to Bone Metabolism and Diseases
Share to Protein Kinase Regulation and GTPase Signaling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20981340
DOI: 10.4061/2010/941419

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SclerostinPMID 20981340Read ↗

Sclerostin: a novel target for intervention in the treatment of osteoporosis.Semantic proximity Read ↗

SclerostinSemantic proximity Read ↗

The Role of Sclerostin in Bone DiseasesSemantic proximity Read ↗

Sclerostin: Current Knowledge and Future PerspectivesSemantic proximity Read ↗

Osteocyte control of bone formation via sclerostin, a novel BMP antagonistSemantic proximity Read ↗

Role of sclerostin in the pathogenesis of chronic kidney disease-mineral bone disorderSemantic proximity Read ↗

Update on romosozumab: a humanized monoclonal antibody to sclerostinSemantic proximity Read ↗

Endocrine functions of sclerostinSemantic proximity Read ↗

The sclerostin story: From human genetics to the development of novel anabolic treatment for osteoporosisSemantic proximity Read ↗

SOST/sclerostin, an osteocyte-derived negative regulator of bone formationSemantic proximity Read ↗

Time-dependent cellular and transcriptional changes in the osteoblast lineage associated with sclerostin antibody treatment in ovariectomized rats.Semantic proximity Read ↗

Sclerostin expression and functions beyond the osteocyteSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.